eAbbvie
Pharmaceutical Product Catalog

Effective January 1, 2019, VIEKIRA XR and TECHNIVIE will no longer be available in the U.S.A. Until January 1, 2019, supply of these medications will be available for all patients who begin therapy prior to July 1, 2018, to ensure that they are able to obtain product necessary to complete their course of prescribed therapy. Accordingly, AbbVie advises that physicians should cease writing any new prescriptions for VIEKIRA XR and TECHNIVIE effective July 1, 2018.

Back To Results
nav nav
ORILISSA 200MG TABS, 4X14 PACK
NDC number: 00074003956
Product Family: ORILISSA
Dosage Form: EA
Strength: 200MG
Imprint: EL 200
Approval Date: 07/23/2018
Controlled Substance: RX
Therapeutic Class:
GNRH ANTAGONIST
   
Price
List Price: $974.54
List Effective Date: 01/01/2021
WAC Price: $974.54
WAC Effective Date: 01/01/2021
Product Dimensions
Each Length (in): 3.14
Each Width (in): 5.91
Each Height (in): 0.44
Packaging Details
Packaging Information
Unit Of Measure: EACH
Inner Pack:
Quantity / Salable Unit: 4X14
Case Size: 24
Total Cases / Pallet: 40
Total Pallet Weight (lbs): 1021.00
Number of Tiers:
Cases / Tier:
Case Details
Case Weight (lbs): 13.63
Case Volume (cu ft): 1352.64
Length (in) Width (in) Height (in)
Outer Case 10.38 18.63 7.00
Inner Case
Announcements
Additional Information

Material Safety Data Sheet

Images 9.2019

Product and pricing detail may change. Please return to www.e-abbvie.com for the current product and pricing information.
Copyright © Abbvie Version 2.5